🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia

RecruitingNAAges 6 Years - anyAllIndiana University
NCT07288827 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to look at children with PCD and see if they have another condition called "bronchial hyperresponsiveness".

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Confirmed diagnosis of PCD per standard diagnostic criteria4 and positive genetics * Age greater than or equal to 6 years (no upper age limit) * Any gender or race * Able to perform pulmonary function testing (historical documentation of reversibility will be accepted) Exclusion Criteria: * history of current pneumothorax * inability to perform pulmonary function testing
💊

What it tests

  • Lung Function Testing
  • Phlebotomy
  • Allergy skin prick testing
  • Methacholine Challenge
📍

Where

1 site
Riley Hospital for Children
Indianapolis, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy